Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
Clinical trial NCT06313398 · RECRUITING
Trial details
- NCT number
- NCT06313398
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-17
- Primary completion
- 2029-05-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.